Xtant Medical Holdings Inc (XTNT) - Total Liabilities
Based on the latest financial reports, Xtant Medical Holdings Inc (XTNT) has total liabilities worth $43.19 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore XTNT net assets growth trend to track the company's year-over-year net asset growth rate.
Xtant Medical Holdings Inc - Total Liabilities Trend (2008–2025)
This chart illustrates how Xtant Medical Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Xtant Medical Holdings Inc to measure how efficiently the company converts operating cash flow to free cash.
Xtant Medical Holdings Inc Competitors by Total Liabilities
The table below lists competitors of Xtant Medical Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Boustead Heavy Industries
KLSE:8133
|
Malaysia | RM141.62 Million |
|
Pansari Developers Limited
NSE:PANSARI
|
India | Rs3.30 Billion |
|
OptimumBank Holdings, Inc.
NYSE MKT:OPHC
|
USA | $1.14 Billion |
|
Lark Distilling Co. Ltd
AU:LRK
|
Australia | AU$7.02 Million |
|
Ta Chia Yung Ho Machine Industry Co Ltd
TWO:2221
|
Taiwan | NT$510.78 Million |
|
Polaris Office Corp
KQ:041020
|
Korea | ₩132.65 Billion |
|
Formosa Prosonic Industries
KLSE:9172
|
Malaysia | RM102.68 Million |
|
Forian Inc
NASDAQ:FORA
|
USA | $14.35 Million |
Liability Composition Analysis (2008–2025)
This chart breaks down Xtant Medical Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Xtant Medical Holdings Inc worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.65 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.85 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Xtant Medical Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Xtant Medical Holdings Inc (2008–2025)
The table below shows the annual total liabilities of Xtant Medical Holdings Inc from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $43.19 Million | -15.10% |
| 2024-12-31 | $50.87 Million | +23.29% |
| 2023-12-31 | $41.26 Million | +58.35% |
| 2022-12-31 | $26.06 Million | +9.45% |
| 2021-12-31 | $23.81 Million | -11.66% |
| 2020-12-31 | $26.95 Million | -69.15% |
| 2019-12-31 | $87.36 Million | -3.14% |
| 2018-12-31 | $90.19 Million | -45.14% |
| 2017-12-31 | $164.40 Million | +8.75% |
| 2016-12-31 | $151.17 Million | +12.66% |
| 2015-12-31 | $134.18 Million | +275.59% |
| 2014-12-31 | $35.73 Million | +9.19% |
| 2013-12-31 | $32.72 Million | +8.12% |
| 2012-12-31 | $30.26 Million | +71.28% |
| 2011-12-31 | $17.67 Million | +7.85% |
| 2010-12-31 | $16.38 Million | +182.41% |
| 2009-12-31 | $5.80 Million | +4418.45% |
| 2008-12-31 | $128.38K | -- |
About Xtant Medical Holdings Inc
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validate… Read more